CytoSorb
CytoSorb is a medical device with 20 clinical trials. Currently 3 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
12 of 14 finished
14.3%
2 ended early
3
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock
CytOSorb TreatMent Of Critically Ill PatientS Registry
Safe and Timely Antithrombotic Removal (STAR) Registry
CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery
Clinical Trials (20)
COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock
CytOSorb TreatMent Of Critically Ill PatientS Registry
Safe and Timely Antithrombotic Removal (STAR) Registry
CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery
Cytokine Filter Usage During Open Thoracoabdominal Aortic Aneurysm Repair- a Single-center Randomized Prospective Trial
Cytokine Adsorption in Lung Transplantation
Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock
Intraoperative Use of Extracorporeal Cytokine Adsorption During Orthotopic Heart Transplantation
CytoSorb SAH Trial
Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19
Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?
Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis
CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS)
Hemadsorption During and After Cardiopulmonary Bypass to Modulate the Inflammatory Response
Extracorporeal Cytokine Adsorption in Cardiac Surgery
Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass
Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal
Cytokine Removal in Cardiopulmonary Bypass Patients
All 20 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 20